Live Breaking News & Updates on Company Rd Day

Stay updated with breaking news from Company rd day. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SpringWorks Therapeutics to Present Progress Across the

NDA filing for Nirogacestat in Desmoid Tumors, Which Will Be Reviewed Under the FDA’s Real-Time Oncology Review (RTOR) Program, Expected in Second Half. ....

United States , Neal Rosen , Mike Burgess , Samantha Hilson Sandler , Enida Haupt , Qa Saqib Islam , Jim Cassidy , Bree Wilky , L Mary Smith , Bhavesh Ashar , Breelyn Wilky , Saqib Islam , Badreddin Edris , Program Update Jim Cassidy , Therapy Combination Development Mike Burgess , Drug Administration , Company Rd Day , Oncology At Memorial Sloan Kettering Cancer Center , Combination Development Jim Cassidy , Inhibitor Program Overview Mike Burgess , University Of Colorado , Springworks Therapeutics Inc , Desmoid Tumors , Which Will Be Reviewed Under , Time Oncology Review , Second Half ,

Investegate |e-Therapeutics plc Announcements | e-Therapeutics plc: Interim results for six months ended 31 July 2021

Investegate announcements from e-Therapeutics plc, Interim results for six months ended 31 July 2021 ....

United Kingdom , City Of , Karl Keegan , Galnacn Acetylgalactosamine , Matthew Johnson Caroline Rowe , Trevor Jones , Vadim Alexandre Rob Rees , Ali Mortazavi , London Stock Exchange , Regulatory Information Service , Registrar Of Companies , Company Rd Day , Sp Angel Corporate Finance , Blenheim Office Park , International Accounting Standard , European Union Withdrawal , Novo Nordisk , Executive Chairman , Professor Trevor Jones , Non Executive Chairman , Period Highlights , Knowledge Graph , Retail Offer , Chief Executive Officer , Market Abuse Regulations , European Union ,

Investegate |Silence Therapeutics Announcements | Silence Therapeutics: Silence Provides Pipeline Updates at 2021 R&D Day

Investegate announcements from Silence Therapeutics, Silence Provides Pipeline Updates at 2021 R&D Day ....

New York , United States , City Of , United Kingdom , Giles Campion , Mark Rothera , Mary Conway , Daniel Adams Gary Clarence , Mallinckrodt Pharmaceuticals , Exchange Commission On , Investec Bank , Company Rd Day , American Society Of Hematology , Corporate Communications , Program Updates , Consilium Strategic Communications , Silence Therapeutics Provides , Pipeline Updates , New York City , Chief Executive Officer , Silence Therapeutics , Chief Medical Officer , Proprietary Program , American Society , Annual Meeting , Partnered Program ,

Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020

Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
News provided by
Share this article
Share this article
SAN DIEGO, March 11, 2021 /PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced program updates and financial results for the fourth quarter and full year ended December 31, 2020.
2020 was a transformative year for Poseida, as we completed our IPO and became a public company all while advancing multiple programs and substantially expanding the application of our core technologies, enabling us to engineer a portfolio of product candidates designed to overcome the limitations of current cell and gene therapeutics, said Eric Ostertag, M.D., Ph.D., Chief Executive Officer of Poseida. This important progress was ....

United States , Eric Ostertag , Dc Program , Poseida Therapeutics Inc , Company Rd Day , American Society Of Hematology , Development Expenses , Exchange Commission , Program Updates , Poseida Therapeutics , Chief Executive Officer , American Society , Annual Meeting , Emerging Discovery , Specific Gene Editing , Fourth Quarter , Full Year , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , எரிக் ஆஸ்டர்டெக் , நிறுவனம் ர்ட் நாள் , அமெரிக்கன் சமூகம் ஆஃப் ஹீமாட்டாலஜி , வளர்ச்சி செலவுகள் , பரிமாற்றம் தரகு , ப்ரோக்ர்யாம் புதுப்பிப்புகள் , தலைமை நிர்வாகி அதிகாரி ,